Amdocs Limited (NASDAQ:DOX) Given Consensus Recommendation of “Moderate Buy” by Analysts

Shares of Amdocs Limited (NASDAQ:DOXGet Free Report) have been assigned an average recommendation of “Moderate Buy” from the five analysts that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $92.3333.

Several research firms have recently weighed in on DOX. Wall Street Zen raised shares of Amdocs from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. Barclays cut their target price on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating for the company in a research report on Wednesday, February 4th. Wolfe Research reissued a “peer perform” rating on shares of Amdocs in a report on Thursday, November 13th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Amdocs in a report on Tuesday, January 27th. Finally, Stifel Nicolaus reduced their price objective on Amdocs from $97.00 to $88.00 and set a “buy” rating for the company in a research report on Wednesday, February 4th.

Get Our Latest Report on Amdocs

Institutional Investors Weigh In On Amdocs

A number of hedge funds have recently modified their holdings of the business. MidFirst Bank purchased a new stake in shares of Amdocs during the fourth quarter worth about $54,000. Pacer Advisors Inc. bought a new position in Amdocs in the 4th quarter worth approximately $25,506,000. EP Wealth Advisors LLC purchased a new stake in Amdocs during the 4th quarter valued at approximately $631,000. Mackenzie Financial Corp raised its position in shares of Amdocs by 218.0% during the fourth quarter. Mackenzie Financial Corp now owns 118,898 shares of the technology company’s stock valued at $9,644,000 after buying an additional 81,504 shares during the last quarter. Finally, NewEdge Advisors LLC raised its position in shares of Amdocs by 8.6% during the fourth quarter. NewEdge Advisors LLC now owns 11,276 shares of the technology company’s stock valued at $908,000 after buying an additional 897 shares during the last quarter. Institutional investors own 92.02% of the company’s stock.

Amdocs Stock Down 2.2%

Shares of DOX stock traded down $1.52 during midday trading on Monday, reaching $68.29. 238,589 shares of the stock were exchanged, compared to its average volume of 1,401,642. Amdocs has a 1 year low of $65.74 and a 1 year high of $95.41. The firm has a market cap of $7.37 billion, a PE ratio of 13.20, a price-to-earnings-growth ratio of 1.23 and a beta of 0.42. The company’s 50 day moving average is $77.63 and its two-hundred day moving average is $80.47. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.23.

Amdocs (NASDAQ:DOXGet Free Report) last issued its quarterly earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.75 by $0.06. Amdocs had a net margin of 12.47% and a return on equity of 20.19%. The company had revenue of $1.16 billion during the quarter, compared to analyst estimates of $1.15 billion. During the same period last year, the business earned $1.66 EPS. Amdocs’s quarterly revenue was up 4.1% compared to the same quarter last year. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. On average, equities research analysts predict that Amdocs will post 6.21 EPS for the current year.

Amdocs Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Tuesday, March 31st will be given a $0.569 dividend. The ex-dividend date is Tuesday, March 31st. This is a boost from Amdocs’s previous quarterly dividend of $0.53. This represents a $2.28 annualized dividend and a yield of 3.3%. Amdocs’s payout ratio is 40.81%.

About Amdocs

(Get Free Report)

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.

See Also

Analyst Recommendations for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.